ESR1 and breast carcinoma: In certain types of breast cancer, a favorable prognostic effect of increased stromal TILs is reported, e.g., triple-negative tumors [21,27,28], estrogen receptor (ERα) negative cancer [29], and HER2 positive malignancies [21,30].